Switching Therapy in Chronic Myeloid Leukemia
0 意见
• 07/08/23
0
0
嵌入
The panelists, Jorge Cortes, MD; Javier Pinilla-Ibarz, MD, PhD; David Snyder, MD, FACP; and Harry Erba, MD, PhD, share perspectives on clinical scenarios in chronic myeloid leukemia that may prompt a treatment change.
显示更多
脸书评论
SORT BY-
热门评论
-
最新评论